LioCyx‑M (LTCR‑H3‑4)
Advanced primary HBV‑related HCC
Phase 1b/2Active
Key Facts
About Lion TCR
Pioneering mRNA‑based TCR‑T cell immunotherapy for HBV‑driven liver cancer in Asia.
View full company profileAdvanced primary HBV‑related HCC
Pioneering mRNA‑based TCR‑T cell immunotherapy for HBV‑driven liver cancer in Asia.
View full company profile